1. Elevated Serum CD44 Level Is Associated With Unfavorable Outcome in Non-Hodgkin's Lymphoma
by Raija Ristamäki, Heikki Joensuu, Kimmo Lappalainen, Lasse Teerenhovi, and Sirpa Jalkanen
Blood
Volume 90(10):
November 15, 1997
©1997 by American Society of Hematology

2. The epitope mapping.
The epitope mapping. MoAb 1F1 recognizes CD44 transfected cells after incubation with MoAb Hermes-3. Combination of Hermes-3–biotinylated Hermes-3 is used as the negative control. b, biotinylated.
Raija Ristamäki et al. Blood 1997;90:
©1997 by American Society of Hematology

3. The prognostic influence of s-CD44 in all lymphomas and separately in the subgroups of DLCL and low-grade lymphomas.
The prognostic influence of s-CD44 in all lymphomas and separately in the subgroups of DLCL and low-grade lymphomas.
Raija Ristamäki et al. Blood 1997;90:
©1997 by American Society of Hematology